New antibody OSE-279 aims to unleash immune system against tumors
NCT ID NCT05751798
First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 28 times
Summary
This study tests a new drug called OSE-279 that helps the immune system fight cancer by blocking a protein called PD-1. It is for people with advanced solid tumors or lymphomas that have not responded to other treatments. The trial has three parts: first finding the safest dose, then testing it alone or with another drug, and finally measuring how well it shrinks tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Antwerp University Hospital
NOT_YET_RECRUITINGEdegem, 11013, Belgium
-
Centre Eugène Marquis
COMPLETEDRennes, 35000, France
-
Centre Léon Bérard
RECRUITINGLyon, 69373, France
-
Hopital Saint Joseph
RECRUITINGParis, 75014, France
-
Hospital Regional Universitario de Málaga
RECRUITINGMálaga, 2901, Spain
-
Institut Gustave Roussy
RECRUITINGVillejuif, 94805, France
-
Institut Jules Bordet
RECRUITINGAnderlecht, 1070, Belgium
-
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI)
RECRUITINGGirona, 17007, Spain
-
Institut de Cancerologie de l'Ouest
RECRUITINGSaint-Herblain, 44805, France
-
Oncopole
RECRUITINGToulouse, 31059, France
-
University Hospital A Coruña Biomedical Research Institute (INIBIC)
RECRUITINGA Coruña, Spain
Conditions
Explore the condition pages connected to this study.